Results 101 to 110 of about 8,373 (204)

Cardiac amyloidosis

open access: yesAnnales Academiae Medicae Silesiensis
Amyloidosis is a rare disease characterized by an abnormal accumulation of the amyloid protein in tissues. Amyloidosis can be divided into two main subtypes: transthyretin amyloidosis (ATTR-CA) and immunoglobulin light chain amyloidosis (AL-CA ...
Magdalena Balwierz   +2 more
doaj   +1 more source

Refractory IgM AL amyloidosis with massive soft tissue tumors: Rescue with zanubrutinib. A case report

open access: yesCurrent Problems in Cancer: Case Reports
Waldenström macroglobulinemia (WM) is a rare indolent B-cell non-Hodgkin lymphoma with lymphoplasmacytic morphology, associated with immunoglobulin M (IgM) monoclonal gammopathy. The coexistence of WM and immunoglobulin light chain (AL) amyloidosis is an
Piotr Jachimowski   +5 more
doaj   +1 more source

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis. [PDF]

open access: yesBlood Cancer J, 2023
Chakraborty R   +5 more
europepmc   +1 more source

A risk stratification for systemic immunoglobulin light‐chain amyloidosis with renal involvement [PDF]

open access: bronze, 2019
Ting Li   +10 more
openalex   +1 more source

Immunoglobulin light chain amyloidosis involved multiple organs [PDF]

open access: yesQJM: An International Journal of Medicine, 2019
J, Bai, J, Qiao, H, Fang
openaire   +2 more sources

Syndrome in question. Immunoglobulin light chain amyloidosis.

open access: yesAnais brasileiros de dermatologia, 2015
Immunoglobulin light chain amyloidosis is the most common acquired systemic amyloidosis. Its presentation is often insidious and progressive, which may delay diagnosis. The authors describe a rare case of immunoglobulin light chain amyloidosis in a 34-year-old man with scleroderma-like manifestation substantiated by multifarious laboratory ...
Han, Ma   +4 more
openaire   +1 more source

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis. [PDF]

open access: yesFront Immunol, 2022
Yan J   +14 more
europepmc   +1 more source

How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis) [PDF]

open access: yesClinical Lymphoma Myeloma and Leukemia, 2020
Chakra P. Chaulagain   +5 more
openaire   +2 more sources

Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis [PDF]

open access: bronze, 2017
Tamer Rezk   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy